TriVirum is a medical device company that uses edge semiconductor and signal processing technology to build new, innovative medical devices.
TriVirum has raised $9.1M in total funding. The most recent round was Seed. The last funding was announced in June 2023.
TriVirum's investors include Par Equity, Particular Ventures, BBI Capital, Almond Tree Capital Fund.
TriVirum is headquartered in Lincoln, United States.
TriVirum is a medical device company that uses edge semiconductor and signal processing technology to build new, innovative medical devices.
TriVirum is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"TriVirum — Funding & Investors." VCBacked, June 8, 2023, https://www.vcbacked.co/company/trivirum. Accessed August 13, 2026.
VCBacked. (2023). TriVirum — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/trivirum
{{cite web |title=TriVirum — Funding & Investors |url=https://www.vcbacked.co/company/trivirum |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated